Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573566
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardiac ArrestKlinikum Klagenfurt am WörtherseeNot Yet RecruitingNot Applicable
NCT07573566Not Yet Recruiting
Not Applicable
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardia...Klinikum Klagenfurt am Wö...
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal WomenUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07572981Not Yet Recruiting
Not Applicable
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving H...University Hospital, Toul...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07573865
tDCS and Bi-manual Training in Cerebral PalsyKing Fahad Specialist Hospital DammamNot Yet RecruitingNot Applicable
NCT07573865Not Yet Recruiting
Not Applicable
tDCS and Bi-manual Training in Cerebral PalsyKing Fahad Specialist Hos...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07572929
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantMedical College of WisconsinNot Yet RecruitingPhase 2
NCT07572929Not Yet Recruiting
Phase 2
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Meas...Medical College of Wiscon...
NCT07572474
Correlation Between Pinch Grip and Handwriting in School-Age ChildrenOctober 6 UniversityCompleted
NCT07572474Completed
—
Correlation Between Pinch Grip and Handwriting in School-Age ChildrenOctober 6 University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573124
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechanical Lumbar Traction in Lumbar RadiculopathyKhyber Medical University PeshawarRecruitingNot Applicable
NCT07573124Recruiting
Not Applicable
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechani...Khyber Medical University...
NCT07574385
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine IncRecruitingPhase 2
NCT07574385Recruiting
Phase 2
Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyRebel Medicine Inc
NCT07573033
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibular 3rd Molar Surgery.Liaquat College of Medicine and DentistryCompletedPhase 4
NCT07573033Completed
Phase 4
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibul...Liaquat College of Medici...
NCT07573501
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive ImpairmentKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573501Not Yet Recruiting
Not Applicable
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates...Ke Dong, MD
Result Breakdown
Not yet recruiting15 (75%)
Completed2 (10%)
Recruiting2 (10%)
Unknown1 (5%)
not_applicable11 (55%)
Phase 23 (15%)
Phase 12 (10%)
Not Specified2 (10%)
Phase 31 (5%)
Phase 41 (5%)